Kobo Biotech Ltd-$
Kobo Biotech Ltd-$ (KOBO) last traded at ₹5.35, a market capitalisation of ₹12.8 crore. Over the past 52 weeks the stock has ranged between ₹1.99 and ₹9.99. Kobo Biotech Ltd-$ last reported results for the quarter ended Jun 2024, with sales of ₹0 crore and net profit of ₹-1.33 crore. Figures are as of 25 Aug 2026 and are not real time.
Kobo Biotech Ltd-$ share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Kobo Biotech Ltd-$ quarterly results
| ₹ crore | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.21 | 0.17 | 0.79 | 0.23 | 0.2 | 0.2 | 0.25 | 0.34 |
| Operating profit | -0.21 | -0.17 | -0.79 | -0.23 | -0.2 | -0.2 | -0.25 | -0.34 |
| OPM % | — | — | — | — | — | — | — | — |
| Other income | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0.02 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.89 | 1.03 | 1 | 1.01 | 1.02 | 1.03 | 1.01 | 1.01 |
| Profit before tax | -1.1 | -1.2 | -1.79 | -1.22 | -1.22 | -1.23 | -1.26 | -1.33 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net profit | -1.1 | -1.19 | -1.79 | -1.23 | -1.22 | -1.23 | -1.26 | -1.33 |
| EPS (₹) | -0.46 | -0.50 | -0.75 | -0.52 | -0.51 | -0.52 | -0.53 | -0.56 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Kobo Biotech Ltd-$ annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating profit | -0.69 | -2.79 | -10.51 | -1.5 | -0.88 | -1.24 |
| OPM % | — | — | — | — | — | — |
| Net profit | -21.01 | -19.23 | -15.23 | -5.55 | -4.93 | -5.23 |
| EPS (₹) | -8.82 | -8.07 | -6.39 | -2.33 | -2.07 | -2.20 |
TTM is the trailing twelve months to the most recent quarter.
Kobo Biotech Ltd-$ growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- 6%
- 5 Years
- 12%
- 3 Years
- 18%
- TTM
- -6%
- 10 Years
- -3%
- 5 Years
- 3%
- 3 Years
- 19%
- 1 Year
- 106%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- Last Year
- %
Kobo Biotech Ltd-$ shareholding pattern
Promoters held 44.95% at Jun 2026, broadly unchanged since Jun 2025. DIIs 0.00%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 55.05% | 55.05% | 55.04% | 55.05% | 55.05% | 55.05% | 55.05% | 55.05% |
| No. of shareholders | 6,916 | 7,542 | 7,873 | 7,929 | 7,947 | 7,970 | 7,977 | 7,734 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Track Kobo Biotech Ltd-$
Cruxal reads every Kobo Biotech Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.